CHELMSFORD, Mass.--(BUSINESS WIRE)-- ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the LifeVest® wearable cardioverter defibrillator ...

LifeVest Wearable Defibrillator Prescribed by Physicians at All U.S. News and World Report’s #1 Ranked “Top Metro” Hospitals The LifeVest is worn by patients at risk for SCA, providing protection ...

CHELMSFORD, Mass., February 02, 2026--(BUSINESS WIRE)--The ZOLL LifeVest ® team is "going red" for Heart Month in February 2026 in support of the American Heart Association and their Go Red for Women ...

A patient who died when a Zoll LifeVest failed to work has led the manufacturer Zoll Medical and the FDA to issue a safety alert for physicians and patients using the wearable heart monitor and ...

Backed by decades of continuous innovation informed by patient feedback, LifeVest continues to set the standard in the WCD market. LifeVest delivers highly effective, safe therapy for patients at risk ...

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL ®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the complete U.S. rollout of its next generation garment ...

A phase 3 trial of Zoll Medical’s LifeVest has missed its primary endpoint. The study found that people who started using the wearable defibrillator the week after they had a heart attack were as ...

CHELMSFORD, Mass.--(BUSINESS WIRE)-- ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that more than 50,000 patients at high ...

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation LifeVest® wearable cardioverter defibrillator (WCD).

The ZOLL LifeVest® team is “going red” for Heart Month in February 2026 in support of the American Heart Association and their Go Red for Women® initiative to spotlight women's cardiac health. ZOLL®, ...